These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4758839)

  • 1. Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.
    Rein MF; Westervelt FB; Sande MA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):366-71. PubMed ID: 4758839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefazolin in normal and uremic subjects.
    Welling PG; Craig WA; Gordon AL; Kunin CM
    Clin Pharmacol Ther; 1974 Apr; 15(4):344-53. PubMed ID: 4821438
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefazolin plasma concentrations and urinary excretion in patients with renal impairment.
    Czerwinski AW; Pederson JA; Barry JP
    J Clin Pharmacol; 1974 Oct; 14(10):560-6. PubMed ID: 4430733
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of parenteral sodium cephalexin in comparison with cephalothin and cefazolin.
    Regamey C; Libke RD; Clarke JT; Kirby WM
    Infection; 1974; 2(3):132-6. PubMed ID: 4415038
    [No Abstract]   [Full Text] [Related]  

  • 6. Bactericidal activity and pharmacology of cefazolin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1973 Oct; 4(4):396-401. PubMed ID: 4598612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative serum levels and urinary recovery of cefazolin, cephaloridine, and cephalothin in man.
    Cahn MM; Levy EJ; Actor P; Pauls JF
    J Clin Pharmacol; 1974 Jan; 14(1):61-6. PubMed ID: 4588120
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodialysis of cefazolin.
    McCloskey RV; Forland MF; Sweeney MJ; Lawrence DN
    J Infect Dis; 1973 Oct; 128():Suppl:S358-6. PubMed ID: 4744018
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of cefazolin, a new cephalosporin antibiotic.
    Reller LB; Karney WW; Beaty HN; Holmes KK; Turck M
    Antimicrob Agents Chemother; 1973 Apr; 3(4):488-97. PubMed ID: 4790605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The course of serum levels of a new cephalosporin, cephacetrile, as a function of renal elimination capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1491-7. PubMed ID: 4479810
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function.
    Humbert G; Leroy A; Fillastre JP; Oksenhendler G
    Antimicrob Agents Chemother; 1978 Jul; 14(1):40-4. PubMed ID: 686708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency.
    Craig WA; Welling PG; Jackson TC; Kunin CM
    J Infect Dis; 1973 Oct; 128():Suppl:S347-5. PubMed ID: 4744016
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and laboratory evaluation of cefazolin: a new cephalosporin antibiotic in pediatric patients.
    Khan AJ
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):727-33. PubMed ID: 4201317
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absorption and excretion of cephapirin (author's transl)].
    Morikawa A; Maruta H; Mizuno D
    Jpn J Antibiot; 1974 Apr; 27(2):182-4. PubMed ID: 4546584
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Fillastre JP
    Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cephanone in healthy adult volunteers.
    Regamey C; Kirby WM
    Antimicrob Agents Chemother; 1973 Dec; 4(6):589-92. PubMed ID: 4793878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
    Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
    Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of cefazolin in patients with normal and abnormal renal function.
    Levison ME; Levison SP; Ries K; Kaye D
    J Infect Dis; 1973 Oct; 128():Suppl:S354-7. PubMed ID: 4744017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.